This inventor holds 2 USPTO granted patents. Top assignee: Finnish Immunotechnology Ltd.. Active years: 2007-2010.
Location History:
- Geneva, CH (2007)
- Bladdes Phnosopues, CH (2010)
Company Filing History:
Years Active: 2007-2010
Title: Innovations and Contributions of Stylianos E Antonarakis
Introduction
Stylianos E Antonarakis is a notable inventor based in Bladdes Phnosopues, Switzerland. He has made significant contributions to the field of immunology, particularly in understanding autoimmune diseases. With a total of 2 patents, his work has implications for both diagnosis and treatment of complex health conditions.
Latest Patents
Antonarakis's latest patents include groundbreaking inventions related to autoimmune polyendocrinopathy syndrome type I (APS I), also known as autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED). One of his patents focuses on a method for diagnosing diseases related to immune maturation and regulation of immune response. This method involves detecting a specific DNA sequence in biological specimens. Another patent introduces a novel gene and protein associated with APECED, detailing diagnostic and therapeutic uses for both the gene and its mutated forms.
Career Highlights
Stylianos E Antonarakis is affiliated with Finnish Immunotechnology Ltd., where he continues to advance research in immunology. His work has been pivotal in enhancing the understanding of immune system disorders and developing innovative diagnostic tools.
Collaborations
Antonarakis has collaborated with esteemed colleagues such as Kai Krohn and Maarit Heino, contributing to a rich environment of research and innovation.
Conclusion
Stylianos E Antonarakis exemplifies the spirit of innovation in the field of immunology. His patents and collaborative efforts are paving the way for advancements in the diagnosis and treatment of autoimmune diseases.